In prostate cancer, for instance, the intensity of p27 expression was negatively associated with the tumor stage and Gleason scores, and the upregulation of p27 expression was observed in prostate adenocarcinoma cells after hormonotherapy (Nikoleishvili et al., 2007). The gene discussed is CDKN1B; the disease is prostate carcinoma.